Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julia Shi

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
AIDS (London, England)|September 27, 2005
Lack of an effect of atazanavir on steady-state pharmacokinetics of methadone in patients chronically treated for opiate addictionGerald Friedland, Laurie Andrews, Tanya Schreibman, et al.
Disability and Rehabilitation|August 2, 2021
Operationalization, measurement, and health indicators of sedentary behavior in individuals with cerebral palsy: a scoping reviewJulia Shi-Peng Xiong, Sarah E Reedman, Michelle E Kho, et al.
Biophysical Journal|September 4, 2007
The C-terminal transmembrane domain of Bcl-xL mediates changes in mitochondrial morphologyJing-Yi Zheng, Yien-Che Tsai, Pradeep Kadimcherla, et al.
Archives of General Psychiatry|March 3, 2004
Efficacy of disulfiram and cognitive behavior therapy in cocaine-dependent outpatients: a randomized placebo-controlled trialKathleen M Carroll, Lisa R Fenton, Samuel A Ball, et al.
The American Journal of Hospice & Palliative Care|April 23, 2015
Place of Care at End of Life: What Factors Are Associated With Patients' and Their Family Members' Preferences?Alvona Zi Hui Loh, Julia Shi Yu Tan, Tan Jinxuan, et al.
Alcoholism, Clinical and Experimental Research|February 10, 2015
N-methyl-D-aspartate receptor antagonism has differential effects on alcohol craving and drinking in heavy drinkersSuchitra Krishnan-Sarin, Stephanie S O'Malley, Nicholas Franco, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 8, 2019
Influence of combined treatment with naltrexone and memantine on alcohol drinking behaviors: a phase II randomized crossover trialSuchitra Krishnan-Sarin, Stephanie S O'Malley, Nicholas Franco, et al.
Research Square|November 24, 2025
A Preliminary Investigation of Brain Cannabinoid Receptor Type 1 (CB1R) Availability in Men with Opioid Use DisorderAnahita Bassir Nia, Ardavan Mohammad Aghaei, Jeremy Weleff, et al.
Psychopharmacology|May 10, 2026
Neuroimaging as the 'missing link' for preclinical to clinical translation: an example using N-acetylcysteine among individuals with cocaine- and opioid-use disorders receiving methadone treatmentSpencer Birney, Annie Cheng, Theresa Babuscio, et al.
Alcoholism, Clinical and Experimental Research|April 30, 2014
Ethyl glucuronide and ethyl sulfate assays in clinical trials, interpretation, and limitations: results of a dose ranging alcohol challenge study and 2 clinical trialsPeter I Jatlow, Ann Agro, Ran Wu, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
AIDS (London, England)|September 27, 2005
Lack of an effect of atazanavir on steady-state pharmacokinetics of methadone in patients chronically treated for opiate addictionGerald Friedland, Laurie Andrews, Tanya Schreibman, et al.
Disability and Rehabilitation|August 2, 2021
Operationalization, measurement, and health indicators of sedentary behavior in individuals with cerebral palsy: a scoping reviewJulia Shi-Peng Xiong, Sarah E Reedman, Michelle E Kho, et al.
Biophysical Journal|September 4, 2007
The C-terminal transmembrane domain of Bcl-xL mediates changes in mitochondrial morphologyJing-Yi Zheng, Yien-Che Tsai, Pradeep Kadimcherla, et al.
Archives of General Psychiatry|March 3, 2004
Efficacy of disulfiram and cognitive behavior therapy in cocaine-dependent outpatients: a randomized placebo-controlled trialKathleen M Carroll, Lisa R Fenton, Samuel A Ball, et al.
The American Journal of Hospice & Palliative Care|April 23, 2015
Place of Care at End of Life: What Factors Are Associated With Patients' and Their Family Members' Preferences?Alvona Zi Hui Loh, Julia Shi Yu Tan, Tan Jinxuan, et al.
Alcoholism, Clinical and Experimental Research|February 10, 2015
N-methyl-D-aspartate receptor antagonism has differential effects on alcohol craving and drinking in heavy drinkersSuchitra Krishnan-Sarin, Stephanie S O'Malley, Nicholas Franco, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 8, 2019
Influence of combined treatment with naltrexone and memantine on alcohol drinking behaviors: a phase II randomized crossover trialSuchitra Krishnan-Sarin, Stephanie S O'Malley, Nicholas Franco, et al.
Research Square|November 24, 2025
A Preliminary Investigation of Brain Cannabinoid Receptor Type 1 (CB1R) Availability in Men with Opioid Use DisorderAnahita Bassir Nia, Ardavan Mohammad Aghaei, Jeremy Weleff, et al.
Psychopharmacology|May 10, 2026
Neuroimaging as the 'missing link' for preclinical to clinical translation: an example using N-acetylcysteine among individuals with cocaine- and opioid-use disorders receiving methadone treatmentSpencer Birney, Annie Cheng, Theresa Babuscio, et al.
Alcoholism, Clinical and Experimental Research|April 30, 2014
Ethyl glucuronide and ethyl sulfate assays in clinical trials, interpretation, and limitations: results of a dose ranging alcohol challenge study and 2 clinical trialsPeter I Jatlow, Ann Agro, Ran Wu, et al.
Pageof 3